104 articles with Ethicon, Inc.
The verdict was delivered in the Philadelphia Court of Common Pleas on May 17, 2019 and also included $50 million in punitive damages.
The sale of Xiidra to Novartis and TachoSil to Ethicon is part of Takeda's strategy to pare down debt from its $62 billion acquisition of Shire.
Takeda Pharmaceutical Company Limited announced that it has entered into agreements to divest its Xiidra® 5% product to Novartis and its TachoSil® Fibrin Sealant Patch to Ethicon as part of its strategy to focus on business areas core to its long-term growth and facilitate rapid deleveraging following its acquisition of Shire.
Johnson & Johnson (NYSE: JNJ) announced today that Ethicon, Inc., has completed the acquisition of Auris Health, Inc. for approximately $3.4 billion in cash
Auris Health's Robotic Platform Expands Johnson & Johnson's Digital Surgery Portfolio
Portfolio of Products, Education and Training to Help Surgeons Handle Challenging Reoperations
Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP)
Johnson & Johnson announced that it has received a binding offer from Fortive Corporation to acquire its Advanced Sterilization Products (ASP) business, a division of Ethicon, Inc.
New Study Finds Powered Stapler Use Is Associated With Reduced Rates Of Bleeding Complications In Thoracic Surgery For Lung Cancer
Bleeding complications dropped by nearly half when surgeons used a powered stapler as opposed to a manual device in what researchers say is the first real-world assessment of the two technologies in video-assisted thoracoscopic surgery (VATS) for lung cancer.
2/7/2018The June 30, 2017 lawsuit asserts that the EndoWrist violates seven Ethicon patents.
New Absorbable Adjunctive Hemostat From Ethicon Helps Surgeons Control Disruptive Bleeding More Efficiently
SURGICEL Powder is designed to address continuous, broad-surface oozing and stop bleeding fast.
Ethicon's BIOPATCH Protective Disk With CHG Meets New CDC Recommendation and Continues as the Standard of Care to Reduce Intravascular Catheter-Related Blood Stream Infections
BIOPATCH is the only IV dressing proven in multiple meta-analyses and randomized controlled trials to reduce risk of central line associated bloodstream infections in patients with central and arterial lines.
Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek™ 2017
Now, Ethicon is partnering with Johnson & Johnson Health & Wellness Solutions to introduce a new digital platform and smartphone app offering resources and decision-making tools for patients considering weight loss surgery
Ethicon Reports Major Progress On Multi-Year Initiative To Fill Clinical And Economic Evidence Gaps And Expand Access To Bariatric Surgery
Ethicon Launches Proxisure Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Ethicon Release: The CDC Updated Guideline Now Include A Recommendation For Triclosan-Coated Sutures
Ethicon Release: New ECHELON FLEX GST System (45mm) Delivers Benefits Of Precision Stapling Performance To Thoracic And Colorectal Procedures